Filter
1841
Filtered Results: 1841
Text search:
pharmaceutical
products
Featured
Recommendations
167
New Publications
508
Language
Document type
No document type
914
Studies & Reports
364
Guidelines
282
Manuals
99
Strategic & Response Plan
83
Fact sheets
42
Training Material
27
Situation Updates
12
Resource Platforms
9
Infographics
5
Brochures
2
Online Courses
2
Countries / Regions
Global
72
Kenya
71
Ethiopia
63
India
57
Nigeria
41
Western and Central Europe
38
South Africa
38
Sierra Leone
37
Uganda
33
Liberia
33
Ghana
31
Namibia
31
Rwanda
29
Tanzania
27
Nepal
26
Malawi
24
Zambia
24
Ukraine
21
Bangladesh
20
Philippines
19
Africa
19
Latin America and the Carribbean
17
Zimbabwe
15
Cambodia
14
Eastern Europe
14
Indonesia
14
Myanmar / Burma
14
Lesotho
13
South–East Asia Region
13
Eswatini/ Swaziland
12
Syria
10
Botswana
10
West and Central Africa
9
Eastern Europe and Central Asia
9
Congo, Democratic Republic of
8
East and Southern Africa
7
Burkina Faso
6
Guinea
6
Haiti
6
Asia
6
Senegal
5
Venezuela
5
Germany
5
South Sudan
5
Thailand
4
Benin
4
Cameroon
4
Albania
4
Vietnam
4
Russia
4
Pakistan
4
North Macedonia
3
China
3
Fiji
3
Laos
3
Mozambique
3
USA
3
Jordan
3
Middle East and North Africa
3
Western Pacific Region
3
North America
3
Sudan
3
Mali
3
Tajikistan
2
Serbia
2
Kyrgyzstan
2
Afghanistan
2
Peru
2
Jamaica
2
United Kingdom
2
Lebanon
2
Papua New Guinea
2
Brazil
2
Moldova
2
Egypt
2
Georgia
2
Central African Republic
2
Madagascar
2
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Malaysia
1
Mongolia
1
Bulgaria
1
Armenia
1
Dominican Republic
1
Ireland
1
Saudi Arabia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Southern Africa
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Sri Lanka
1
Yemen
1
Honduras
1
Angola
1
Libya
1
Bhutan
1
Iraq
1
Somalia
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
728
Clinical Guidelines
125
Public Health
93
Key Resources
91
Women & Child Health
51
Pharmacy & Technologies
39
Capacity Building
11
Annual Report MEDBOX
1
Toolboxes
Pharmacy
194
AMR
180
COVID-19
126
HIV
85
TB
85
Mental Health
82
NTDs
58
Rapid Response
54
Planetary Health
54
Global Health Education
39
NCDs
36
Caregiver
34
Health Financing Toolbox
34
Ebola & Marburg
33
Conflict
29
Malaria
27
Specific Hazards
13
Refugee
12
Disability
10
Polio
9
Natural Hazards
8
2.0 Rapid Response
4
Social Ethics
3
Zika
3
Cholera
2
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries face challenges with erratic vaccine supplies, use of multiple vaccine products with different charact...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
Accessed: 02.05.2020
These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and Pharmaceu...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic outp...
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide useful when developing and strengthening their sup...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
The Ethiopian Hospital Services Transformation Guidelines (EHSTG) build on and expand the Ethiopian Hospital Reform Implementation Guidelines (EHRIG) and are consistent with the Health Sector Transformation Plan (HSTP). The EHSTG, which is consistent with the national focu...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Translation of the 1st ed., 2003
These guidelines were written for anyone trying to meet and solve the challenges of operating a warehouse today. They are an important reference tool for managers and staff, whether they are constructing a new warehouse, implementing a new warehouse syste...
These guidelines were written for anyone trying to meet and solve the challenges of operating a warehouse today. They are an important reference tool for managers and staff, whether they are constructing a new warehouse, implementing a new warehouse syste...
Training Manual
Information for Migrations
